Psychedelics and the 'inner healer': Myth or mechanism?

Introduction

The paper situates the popular idea of an "inner healer"—an intrinsic, organism-originating process of psychological or neural regeneration—within both historical and contemporary psychedelic use and therapy. Earlier research and cultural traditions frame healing as a teleological, self-directed process that appears across spiritual, psychotherapeutic and psychedelic contexts; however, such notions are often vague and risk conflation with expectation, suggestibility or metaphysical claims. The authors note overlaps between the inner healer theme and operationalised psychedelic constructs already studied, such as emotional breakthrough, psychological insight and the mystical-type experience, and argue that scientific methods are needed to deconstruct and test whether the inner healer denotes a measurable, mechanistic phenomenon rather than mythmaking. Peill and colleagues set out to take an initial, pragmatic step towards validating the inner healer construct. They created a single-item subjective rating intended to capture participants' sense that their body/mind/brain was "healing itself" after a psilocybin session. Using data from a double-blind randomised controlled trial of psilocybin versus escitalopram for major depressive disorder, the investigators tested two main hypotheses: that inner healer scores would be higher after a high (25 mg) versus an inactive (1 mg) psilocybin dose, and that inner healer scores in the 25 mg condition would predict clinical improvement (change in Beck Depression Inventory scores) at 2 weeks post-dosing. The study additionally examined whether baseline suggestibility and expectancy, and generic subjective drug intensity, could explain the inner healer effect, and explored its relationship with established acute-experience measures (MEQ, EBI, CEQ, ASC).